If you are pregnant, nursing, or under medical treatment, consult your physician before considering any compound covered in this article.
For a BPC-157 and TB-500 stack aimed at injury recovery in Quebec, the most commonly used protocol is 250-500 mcg of BPC-157 injected subcutaneously once or twice daily, combined with 2.5-5 mg of TB-500 injected twice weekly for 4-6 weeks. This combination targets both localized tissue repair and systemic healing. The dosages are consistent with research on peptides for recovery, and many Quebec-based researchers source these peptides from domestic suppliers to avoid customs delays.
Why Stack BPC-157 and TB-500 for Injury Recovery?
BPC-157 is a pentadecapeptide derived from gastric juice that promotes angiogenesis, fibroblast migration, and collagen production at the injury site. TB-500, a synthetic fragment of thymosin beta-4, acts systemically to reduce inflammation, increase cell migration, and support muscle and tendon repair. When stacked, they work through complementary pathways: BPC-157 accelerates local healing, while TB-500 enhances whole-body recovery. This synergy is why the combination is popular among athletes and researchers in Quebec dealing with tendon, ligament, or muscle injuries.
Clinical data on BPC-157 is largely from animal models, but it shows accelerated healing of tendon-to-bone interfaces and reduced recovery time after muscle tears. TB-500 has been studied in horses and rodents for similar outcomes. For human use, anecdotal reports suggest faster return to activity and less residual pain when the two are combined versus either alone. A typical TB-500 dosage for muscle recovery is often discussed alongside BPC-157 protocols.
BPC-157 Dosage for Injury Recovery
The standard BPC-157 dosage for injury recovery is 250-500 mcg per injection. Most researchers split this into two daily doses: one in the morning and one before bed. The injection is subcutaneous, ideally as close to the injury site as possible, though systemic effects occur regardless of location. For a 5 mg vial, reconstitute with 2 ml of bacteriostatic water to get a concentration of 2500 mcg/ml. Then a 250 mcg dose is 0.1 ml (10 units on an insulin syringe).
Cycle length for BPC-157 is typically 4-6 weeks, followed by a 2-week break. Some protocols extend to 8 weeks for severe injuries, but longer cycles may reduce receptor sensitivity. In Quebec, researchers often buy BPC-157 5 mg vials from local peptide suppliers to ensure fast shipping and proper storage. The peptide should be kept refrigerated after reconstitution and used within 30 days.
TB-500 Dosage for Injury Recovery
TB-500 is dosed differently due to its longer half-life. The common protocol is 2.5-5 mg injected subcutaneously or intramuscularly twice per week. A loading phase of 4-6 weeks is standard, with some protocols using a higher initial dose of 5 mg twice weekly for the first two weeks, then dropping to 2.5 mg twice weekly for maintenance. For a 5 mg vial, reconstitute with 1-2 ml of bacteriostatic water. A 2.5 mg dose is then 0.5-1 ml depending on concentration.
TB-500 can be injected anywhere subcutaneously; site-specific injection is not required because it works systemically. Many users in Quebec combine TB-500 with BPC-157 by injecting both on the same day but at different sites. The TB-500 dosage for recovery is often adjusted based on body weight and injury severity, but 5 mg per week total is a common starting point. For more detailed guidance, see this TB-500 dosage guide for Quebec researchers.
Combined Stack Protocol and Timing
When stacking BPC-157 and TB-500, timing matters. BPC-157 has a short half-life, so daily dosing is necessary. TB-500 has a half-life of several days, so twice-weekly dosing is sufficient. A practical schedule is:
- Morning: BPC-157 250-500 mcg subcutaneous injection near injury site
- Evening: BPC-157 250-500 mcg subcutaneous injection (optional second dose)
- Monday and Thursday: TB-500 2.5-5 mg subcutaneous or intramuscular injection
This protocol keeps BPC-157 levels steady while allowing TB-500 to accumulate. Some researchers add a third TB-500 dose in the first week as a loading phase. The total cycle is usually 6 weeks, followed by 2-4 weeks off. During the off period, some switch to other recovery peptides like MOTS-c for energy and metabolic support, though that is not a direct substitute.
Reconstitution and Storage in Quebec
Proper reconstitution is critical for peptide stability. Use bacteriostatic water, not sterile water, to prevent bacterial growth. For BPC-157, a 5 mg vial with 2 ml of bacteriostatic water yields 2500 mcg/ml. For TB-500, a 5 mg vial with 1 ml of water yields 5 mg/ml. Always let the water drip down the vial wall slowly to avoid damaging the peptide. Store reconstituted peptides in the refrigerator at 2-8 degrees Celsius. Do not freeze after reconstitution.
In Quebec, summer humidity and winter cold can affect shipping. Choose a supplier that ships with ice packs and tracking. Many researchers buy BPC-157 and TB-500 together as a stack kit to save money. The peptides should arrive as lyophilized powder, which is stable at room temperature for a few weeks but should be refrigerated immediately upon arrival.
Expected Results and Timeline
Most users report noticeable improvement in pain and mobility within 2-3 weeks of starting the BPC-157 and TB-500 stack. Full recovery from moderate tendon or ligament injuries may take 6-8 weeks. For chronic injuries, a second cycle after a break is often needed. The peptides do not provide immediate pain relief like NSAIDs; they accelerate the underlying healing process. Combining the stack with physical therapy yields the best outcomes.
Some Quebec researchers track progress using range-of-motion tests and pain scales. A common report is reduced morning stiffness and faster return to training. However, results vary based on injury type, age, and overall health. The stack is not a replacement for medical care; anyone with a serious injury should consult a healthcare provider.
Side Effects and Safety Considerations
BPC-157 and TB-500 are generally well tolerated in research settings. Reported side effects are mild and may include injection site redness, fatigue, or headache. Some users experience a temporary increase in appetite with BPC-157. TB-500 may cause a brief feeling of warmth or flushing after injection. No serious adverse events have been reported in human use at typical dosages, but long-term safety data is lacking.
Because these peptides are not approved by Health Canada for human use, they are sold for research purposes only. In Quebec, purchasing peptides for personal use falls into a gray area. Researchers should ensure they buy from reputable suppliers that provide third-party testing. Avoid products sold as "for human consumption" as that is a red flag.
Where to Buy BPC-157 and TB-500 in Quebec
Several online peptide suppliers ship to Quebec from within Canada. Look for vendors that offer lab reports, discreet packaging, and fast shipping. Prices for a BPC-157 5 mg vial range from $30 to $60 CAD, while TB-500 5 mg vials range from $40 to $80 CAD. Buying a stack kit often reduces the cost by 10-20%. Some popular options include Canadian peptide shops and research chemical suppliers based in Ontario or Quebec.
When buying peptides in Quebec, consider shipping time and customs risk. Domestic suppliers avoid border delays, which is important for temperature-sensitive peptides. Always verify the supplier's reputation through forums and reviews. For a broader look at peptide protocols in Quebec, see this guide on Sermorelin dosage for fat loss, which covers similar sourcing considerations.
Frequently Asked Questions
Can I inject BPC-157 and TB-500 at the same time?
Yes, they can be injected on the same day, but use separate syringes and different injection sites. Do not mix them in the same syringe because the pH and stability may differ. Space the injections by at least a few hours if possible.
How long should I run the BPC-157 and TB-500 stack?
The typical cycle is 4-6 weeks. Some researchers extend to 8 weeks for severe injuries, but a break of 2-4 weeks is recommended afterward. Cycling prevents receptor downregulation and maintains effectiveness.
Is a prescription required for BPC-157 or TB-500 in Quebec?
These peptides are not approved for human use by Health Canada, so no prescription is available. They are sold as research chemicals. Possession for personal research is generally tolerated, but selling for human consumption is illegal.
Can I use this stack for muscle recovery after surgery?
Many people use BPC-157 and TB-500 post-surgery to speed healing. However, always inform your surgeon, as these peptides can affect bleeding and inflammation. Do not use them immediately before or after surgery without medical supervision.
Final Thoughts on the BPC-157 and TB-500 Stack
The BPC-157 and TB-500 stack is a well-regarded protocol for injury recovery in the peptide research community. The dosages outlined here are based on common practice and anecdotal reports, not clinical trials. If you are in Quebec and considering this stack, start with the lower end of the dosage range and monitor your response. Combine the peptides with proper nutrition, sleep, and rehabilitation for the best results. For those interested in other recovery-focused peptides, this comparison of CJC-1295 and Tesamorelin offers additional insights into growth hormone secretagogues.